Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: August 2024

MissionIRNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth

InMed Pharmaceuticals’ (NASDAQ: INM) subsidiary BayMedica is positioned amid a growing interest in edibles infused with non-intoxicating minor cannabinoids. These lesser-known cannabinoids offer unique properties and potential health benefits, driving significant market growth. The company published a report on the … Continue reading

Posted in Small Cap News | Leave a comment

MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Expands Team in Continued Focus to Make Meaningful Impact on Lives of AD, PD Patients

Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), recently welcomed four seasoned professionals to its executive team. “Annovis Bio is excited … Continue reading

Posted in Annovis Bio Inc. ANVS | Leave a comment

SenesTech Inc. (NASDAQ: SNES) Continues to Grow, Offering Industry’s Only Soft Bait that Restricts Fertility in Rodents, as Dangers of Rodenticides Rise

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, recently issued new unregistered warrants to purchase up to an aggregate of 1,011,004 shares of common stock at $4.35 per unit in a private placement. The company … Continue reading

Posted in SenesTech Inc. SNES | Leave a comment

MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Facilitating Global Transition Toward Solar

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation. “With its unique market positioning, Correlate is facilitating the global … Continue reading

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Expands National Dealer Network Westward with 20 Locations

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is announcing that its subsidiary, Bollinger Motors, has added TEC Equipment, Inc. to its sales and service network. The move, which adds 20 select sales and service locations, expands the … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy

InMed Pharmaceuticals (NASDAQ: INM), a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors, announced that its drug candidate INM-901 as an oral formulation will be used in its development … Continue reading

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positions Itself in Key PGM Space

Platinum Group Metals (NYSE American: PLG) (TSX: PTM), a company that operates the Waterberg PGM Project in South Africa, is strengthening its foothold in a niche sector of mining: platinum group metals (“PGMs”). The company’s primary business objective is to advance … Continue reading

Posted in Platinum Group Metals Ltd. PLG | Leave a comment

MissionIRNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Launches Comprehensive B2B Marketing Campaign to Drive Sales Growth into 2025

SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”), a provider of next-generation transdermal alcohol detection solutions, today announced the launch of a new national campaign to introduce the SOBRsafe(TM) technology to behavioral health providers and drive sales growth into 2025. The comprehensive B2B … Continue reading

Posted in SOBRsafe Inc. SOBR | Leave a comment

Clene Inc.’s (NASDAQ: CLNN) CEO Discusses Company’s Mission, CNM-Au8(R) Trial Results, and Future Plans on BioMedWire Podcast

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, was recently featured on The BioMedWire Podcast, highlighting the important results of CNM-Au8 trials for both amyotrophic lateral sclerosis … Continue reading

Posted in Clene Inc. CLNN | Leave a comment

SOBRsafe Inc. (NASDAQ: SOBR) Continues to Fortify Its Financial Position and Grow in the Behavioral Health Market

SOBRsafe (NASDAQ: SOBR), the provider of next-generation transdermal alcohol detection solutions, has continued to implement plans and strategies to strengthen its financial position and restructure shareholder equity throughout the second quarter of its 2024 financial year, according to its recent … Continue reading

Posted in SOBRsafe Inc. SOBR | Leave a comment